INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS

What INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS does

The Instituto Nacional de Enfermedades Respiratorias (INER) is a Mexican federal government healthcare institution established in 1942 and headquartered in Mexico City, operating as part of the national public health system under the Secretaría de Salud. It functions as Mexico's designated national reference center for respiratory diseases, providing specialized medical services that include pulmonary transplantation, early lung cancer detection through its DETECAP program, pulmonary function testing, and broader pneumology and thoracic surgery care. The institution serves patients referred within Mexico's public healthcare system and operates with approximately 950 employees.

INER's portfolio extends beyond direct clinical care into medical education and research. It runs the Escuela Superior de Terapia Respiratoria (undergraduate respiratory therapy), the Escuela de Enfermería Aurelia Saldierna Rodríguez (undergraduate nursing and, as of 2026, a postgraduate nursing specialization for the 2027–2028 cohort), and a medical residency program covering respiratory and thoracic medicine. Its research output is channeled through the peer-reviewed Revista de Neumología y Cirugía de Tórax and the INER Informa digital magazine, and its research infrastructure is organized through a dedicated Dirección de Investigación.

As a government state entity, INER is funded through federal health appropriations rather than commercial revenue; no pricing model, revenue figure, or investor base is disclosed. Its governance is structured around six directorates — General, Médica, Administración y Finanzas, Planeación y Desarrollo Organizacional, Enseñanza, and Investigación — under Director General Dra. Carmen Margarita Hernández Cárdenas, appointed in July 2023. No commercial partnerships, M&A activity, private capital, or foreign-market operations are present in the data.

Name

INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS

Legal name

Instituto Nacional de Enfermedades Respiratorias

Website

https://iner.gob.mx

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Instituto Nacional de Enfermedades Respiratorias is Mexico's federal national reference center for respiratory disease treatment, medical education, and research, operating as a public institution under the Secretaría de Salud with about 950 staff in Mexico City.

Ownership category

akta.pro rank

Product category

Specialty Respiratory Healthcare

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro industry

PRIMARYHLAKANAA

General Pulmonology Practice

Healthcare & Life Sciences/Specialist Medical Practice/Pulmonology & Sleep Medicine

SECONDARYHLAFAKAJ

Pulmonary Function & Respiratory Diagnostic Centers (PFT/Spirometry)

Healthcare & Life Sciences/Healthcare Providers & Systems/Diagnostic & Imaging Centers

Keywords

• Respiratory healthcare
• Pulmonary medicine
• Medical research
• Medical education
• Lung transplantation

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Distribution channels1 record

Marketing channels3 records

Core offering

INER is Mexico's national reference center for respiratory diseases, providing specialized medical care for the diagnosis, treatment, and management of pulmonary and thoracic conditions. The institution delivers lung transplantation, early lung cancer detection, and pulmonary function testing, alongside higher education programs in respiratory therapy and nursing, medical residency training, and clinical research in pneumology and thoracic surgery.

Product overview

Instituto Nacional de Enfermedades Respiratorias (INER) is a Mexican government healthcare institution specializing in respiratory medicine. The institution operates as a unified medical center offering specialized patient care services alongside educational programs. Its portfolio includes core medical services for respiratory disease diagnosis and treatment, educational offerings (respiratory therapy school, nursing school, medical residency programs), specialized programs (lung transplant, early lung cancer detection), and academic publications (digital magazine and scientific journal).

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights4 records

Emerging players

• Hospital Israelita Albert Einstein: Leading Latin American private academic hospital with strong pulmonology and thoracic surgery programs. Comparable to INER as an integrated care-research-teaching institution, though privately funded and Brazil-based.
• Fundación Jiménez Díaz: Spanish academic hospital with a leading respiratory medicine department. Comparable in profile to INER as a specialty pulmonology and thoracic surgery referral center integrated with research and teaching.

Regional players

• Hospital Clínic de Barcelona: European academic hospital internationally recognized for respiratory medicine research. Comparable to INER in combining high-complexity pulmonology care with translational research, though serving a different geography and population.
• Hospital Español de México: Large Mexico City private hospital with pulmonology and thoracic surgery capabilities. Competes with INER for privately insured and out-of-pocket patients seeking faster access to specialty respiratory care.

Direct peers

• Hospital Infantil de México Federico Gómez: Mexican federal national pediatric specialty hospital. Operates under the same Secretaría de Salud structure as INER, with integrated teaching, research, and high-complexity pediatric care.
• Instituto Nacional de Cardiología Ignacio Chávez: Mexican federal national institute specializing in cardiology, with the same public-sector, multi-mission (care + research + education) operating model as INER, applied to a different organ specialty.
• Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ): Another Mexican federal national health institute under the Secretaría de Salud. It shares INER's institutional model of combining specialty tertiary care, research, and teaching, making it the closest structural peer in the Mexican public health system.
• Instituto Nacional de Cancerología (INCan): Mexico's national cancer institute under federal health authorities. Comparable to INER as a specialty national institute offering complex procedures (e.g., thoracic oncology), research, and medical residencies.

Broad incumbents

• Hospital General de México: One of Mexico's largest public general hospitals, also under federal administration. Provides broader specialty coverage than INER and serves as a major referral competitor for general respiratory cases.
• Hospital de Especialidades del Centro Médico Nacional Siglo XXI (IMSS): IMSS-administered specialty hospital serving Mexico's social-security-insured population. Overlaps with INER on respiratory and thoracic cases for insured patients, making it a partial substitute within the public system.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/GobiernoMX
• YouTubeyoutube.com/@gobiernodemexico
• Facebookfacebook.com/gobmexico
• Instagraminstagram.com/gobmexico
• LinkedInlinkedin.com/company/instituto-nacional-de-enfermedades-respiratorias

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS